(Q37046156)

17 August 2017

1 reference

title

Human papillomavirus infection and the development of cervical cancer and related genital neoplasias (English)

1 reference

human papillomavirus infection

17 August 2017

main subject

1 reference

inferred from title

cervix uterine cancer

1 reference

1

Jorma Paavonen

1 reference

17 August 2017

publication date

1 November 2007

1 reference

International Journal of Infectious Diseases

17 August 2017

published in

1 reference

17 August 2017

volume

11 Suppl 2

1 reference

17 August 2017

page(s)

S3-9

1 reference

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

A population-based study of squamous cell vaginal cancer: HPV and cofactors

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Latent Human Papillomavirus infection is comparable in the larynx and trachea

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Recurrent respiratory papillomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Impact of HPV infection in adolescent populations

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Classification of papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Progress on new vaccine strategies against chronic viral infections

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Chapter 2: The burden of HPV-related cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Epidemiologic classification of human papillomavirus types associated with cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Genital Human Papillomavirus Infection in Female University Students as Determined by a PCR-Based Method

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Natural history of cervicovaginal papillomavirus infection in young women.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Seroprevalence of human papillomavirus type 16 infection in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

High incidence of cervical human papillomavirus infection in women during their first sexual relationship

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

High prevalence of HPV among female students in Finland.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Epidemiology, diagnosis and treatment of vulvar intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

In situ and invasive vulvar cancer incidence trends (1973 to 1987)

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Epidemiology of Genital Human Papillomavirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Human papillomavirus and cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Development and duration of human papillomavirus lesions, after initial infection

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

External genital warts: diagnosis, treatment, and prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Physical and psychological effects of anogenital warts on female patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Genital warts: a study of patient anxiety and information needs.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Advice from affected persons about living with human papillomavirus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Trends in Cervical Squamous Cell Carcinoma Incidence in 13 European Countries: Changing Risk and the Effects of Screening

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Reducing the health burden of HPV infection through vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Prevention of cervical cancer through papillomavirus vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Cervical cancer screening programmes and policies in 18 European countries

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960015-0

7 January 2021

10.1016/S1201-9712(07)60015-0

Identifiers

DOI

1 reference

17 August 2017

1 reference